215 related articles for article (PubMed ID: 17029275)
1. Long-term outcome of hematuria home screening for bladder cancer in men.
Messing EM; Madeb R; Young T; Gilchrist KW; Bram L; Greenberg EB; Wegenke JD; Stephenson L; Gee J; Feng C
Cancer; 2006 Nov; 107(9):2173-9. PubMed ID: 17029275
[TBL] [Abstract][Full Text] [Related]
2. Comparison of bladder cancer outcome in men undergoing hematuria home screening versus those with standard clinical presentations.
Messing EM; Young TB; Hunt VB; Gilchrist KW; Newton MA; Bram LL; Hisgen WJ; Greenberg EB; Kuglitsch ME; Wegenke JD
Urology; 1995 Mar; 45(3):387-96; discussion 396-7. PubMed ID: 7879333
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcome of patients with a negative work-up for asymptomatic microhematuria.
Madeb R; Golijanin D; Knopf J; Davis M; Feng C; Fender A; Stephenson L; Messing EM
Urology; 2010 Jan; 75(1):20-5. PubMed ID: 19913883
[TBL] [Abstract][Full Text] [Related]
4. Feasibility study of screening for bladder cancer with urinary molecular markers (the BLU-P project).
Roobol MJ; Bangma CH; el Bouazzaoui S; Franken-Raab CG; Zwarthoff EC
Urol Oncol; 2010; 28(6):686-90. PubMed ID: 21062653
[TBL] [Abstract][Full Text] [Related]
5. Grade and stage at presentation do not predict mortality in patients with bladder cancer who survive their disease.
Messing EM; Madeb R; Feng C; Stephenson L; Gilchrist KW; Young T; Gee J
J Clin Oncol; 2009 May; 27(15):2443-9. PubMed ID: 19332735
[TBL] [Abstract][Full Text] [Related]
6. Bladder cancer screening in a high risk asymptomatic population using a point of care urine based protein tumor marker.
Lotan Y; Elias K; Svatek RS; Bagrodia A; Nuss G; Moran B; Sagalowsky AI
J Urol; 2009 Jul; 182(1):52-7; discussion 58. PubMed ID: 19450825
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcome of hematuria home screening for bladder cancer in men.
Cai T; Bartoletti R
Cancer; 2007 May; 109(9):1923-4; author reply 1924. PubMed ID: 17357998
[No Abstract] [Full Text] [Related]
8. Outcomes of a bladder cancer screening program using home hematuria testing and molecular markers.
Bangma CH; Loeb S; Busstra M; Zhu X; El Bouazzaoui S; Refos J; Van Der Keur KA; Tjin S; Franken CG; van Leenders GJ; Zwarthoff EC; Roobol MJ
Eur Urol; 2013 Jul; 64(1):41-7. PubMed ID: 23478169
[TBL] [Abstract][Full Text] [Related]
9. Screening for bladder tumours in men aged 60-70 years with a bladder tumour marker (UBC) and dipstick-detected haematuria using both white-light and fluorescence cystoscopy.
Hedelin H; Jonsson K; Salomonsson K; Boman H
Scand J Urol Nephrol; 2006; 40(1):26-30. PubMed ID: 16452052
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcome of home dipstick testing for hematuria.
Madeb R; Messing EM
World J Urol; 2008 Feb; 26(1):19-24. PubMed ID: 18040694
[TBL] [Abstract][Full Text] [Related]
11. Can hematuria be a predictor as well as a symptom or sign of bladder cancer?
Friedman GD; Carroll PR; Cattolica EV; Hiatt RA
Cancer Epidemiol Biomarkers Prev; 1996 Dec; 5(12):993-6. PubMed ID: 8959322
[TBL] [Abstract][Full Text] [Related]
12. Bladder cancer screening.
Kryger JV; Messing E
Semin Oncol; 1996 Oct; 23(5):585-97. PubMed ID: 8893869
[TBL] [Abstract][Full Text] [Related]
13. Dipstick urinalysis screening, asymptomatic microhematuria, and subsequent urological cancers in a population-based sample.
Hiatt RA; Ordoñez JD
Cancer Epidemiol Biomarkers Prev; 1994; 3(5):439-43. PubMed ID: 7848421
[TBL] [Abstract][Full Text] [Related]
14. Early results of bladder-cancer screening in a high-risk population of heavy smokers.
Steiner H; Bergmeister M; Verdorfer I; Granig T; Mikuz G; Bartsch G; Stoehr B; Brunner A
BJU Int; 2008 Aug; 102(3):291-6. PubMed ID: 18336612
[TBL] [Abstract][Full Text] [Related]
15. Does photodynamic transurethral resection of bladder tumour improve the outcome of initial T1 high-grade bladder cancer? A long-term follow-up of a randomized study.
Denzinger S; Wieland WF; Otto W; Filbeck T; Knuechel R; Burger M
BJU Int; 2008 Mar; 101(5):566-9. PubMed ID: 17986289
[TBL] [Abstract][Full Text] [Related]
16. Overall survival in the intervention arm of a randomized controlled screening trial for prostate cancer compared with a clinically diagnosed cohort.
Vis AN; Roemeling S; Reedijk AM; Otto SJ; Schröder FH
Eur Urol; 2008 Jan; 53(1):91-8. PubMed ID: 17583416
[TBL] [Abstract][Full Text] [Related]
17. Non-bladder cancer mortality in patients with urothelial cancer of the bladder.
Scosyrev E; Wu G; Golijanin D; Messing E
Urol Oncol; 2013 Jul; 31(5):656-63. PubMed ID: 21550827
[TBL] [Abstract][Full Text] [Related]
18. Patterns of hematuria referral to urologists: does a gender disparity exist?
Johnson EK; Daignault S; Zhang Y; Lee CT
Urology; 2008 Sep; 72(3):498-502; discussion 502-3. PubMed ID: 18619657
[TBL] [Abstract][Full Text] [Related]
19. [Influence of blood cells in urine samples on results of screening for urothelial carcinoma with NMP22 bladder chek].
Ueda Y; Kawaguchi R; Takiuchi H; Kokura K; Yoshimoto T; Mitsui Y; Suzuki T; Jun Q; Higuchi Y; Maruyama T; Kondoh N; Nozima M; Yamamoto S; Shima H
Hinyokika Kiyo; 2009 Feb; 55(2):71-4. PubMed ID: 19301610
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
